These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 82342)

  • 21. Intermittent application of clobetasol-17-propionate in psoriasis.
    Young E; van der Velde EA
    Curr Med Res Opin; 1987; 10(7):468-73. PubMed ID: 3621992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clobetasol--a potent new topical corticosteroid.
    Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis.
    Griffiths CE; Powles AV; Baker BS; Fry L; Valdimarsson H
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):50-2. PubMed ID: 3381302
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
    Rigopoulos D; Gregoriou S; Katsambas A
    Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of a corticosteroid cream for immediate reduction in the clinical signs of acne vulgaris.
    Hull SM; Cunliffe WJ
    Acta Derm Venereol; 1989; 69(5):452-3. PubMed ID: 2572120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial.
    Menter A
    Cutis; 2007 Nov; 80(5 Suppl):12-9. PubMed ID: 18154219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis.
    Katoh N; Kishimoto S
    Eur J Dermatol; 2003; 13(4):382-4. PubMed ID: 12948920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
    Rozman TA; Wiedey KD; Renovanz HD
    Z Hautkr; 1983 Mar; 58(6):398-409. PubMed ID: 6342288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB; Gold MH; Zib B; Davis MW;
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
    Jegasothy B; Jacobson C; Levine N; Millikan L; Olsen E; Pinnell S; Cole G; Weinstein G; Porter M
    Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two application schedules for clobetasol 17 propionate.
    vd Harst LC; de Jonge H; Pot F; Polano MK
    Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
    Eriksen K
    Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.
    Sánchez Regaña M; Martín Ezquerra G; Umbert Millet P; Llambí Mateos F
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):573-7. PubMed ID: 16164711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate.
    Lidbrink P; Johannesson A; Hammar H
    Dermatologica; 1986; 172(3):164-8. PubMed ID: 3699218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
    Bovenschen HJ; Vissers WH; Seyger MM; van de Kerkhof PC
    Acta Derm Venereol; 2005; 85(2):113-7. PubMed ID: 15823902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cortisol studies with 0.05% halometasone cream and ointment in patients with psoriasis.
    Tomasini C; Castiglioni G
    J Int Med Res; 1983; 11 Suppl 1():38-42. PubMed ID: 6832467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
    Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
    Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
    [No Abstract]   [Full Text] [Related]  

  • 39. A clinical comparison of betamethasone 17,21-dipropionate and clobetasol propionate creams in dermatology.
    Voigtländer V
    J Int Med Res; 1977; 5(2):128-31. PubMed ID: 326594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
    Brodell R; Preston N
    J Drugs Dermatol; 2012 Dec; 11(12):1455-9. PubMed ID: 23377516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.